First-time presentation examining bone outcomes in early postmenopausal women
Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting
Seeking Alpha / 1 hour from now 1 Views
First-time presentation examining bone outcomes in early postmenopausal women
Comments